250.08

1.00% -2.52

Pre-market: 246.00 -4.08 -1.63%

Bio Rad Laboratories Inc (BIO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Rad Laboratories Inc stock is traded at $250.08, with a volume of 408.77K. It is down -1.00% in the last 24 hours and up +2.50% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Previous Close:

$252.60

Open:

$253.06

24h Volume:

408.77K

Relative Volume:

1.19

Market Cap:

$5.54B

Revenue:

$2.58B

Net Income/Loss:

$-778.69M

P/E Ratio:

-9.1504

EPS:

-27.33

Net Cash Flow:

$223.75M

1W Performance:

-2.72%

1M Performance:

+2.50%

6M Performance:

-30.31%

1Y Performance:

-26.50%

1-Day Range:

$247.80

$255.15

1-Week Range:

$247.80

$267.49

52-Week Range:

$211.43

$387.99

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name

Bio Rad Laboratories Inc

Sector

Healthcare (1166)

Industry

Medical Devices (149)

Phone

(510) 724-7000

Address

1000 ALFRED NOBEL DRIVE, HERCULES

Employee

7,700

Twitter

@BioRadLifeSci

Next Earnings Date

2024-10-30

Latest SEC Filings

BIO's Discussions on Twitter

Compare BIO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIO Bio Rad Laboratories Inc	250.08	6.87B	2.58B	-778.69M	223.75M	-27.33
ABT Abbott Laboratories	128.55	222.72B	43.11B	13.98B	6.66B	7.98
BSX Boston Scientific Corp	106.76	157.52B	18.49B	2.51B	2.72B	1.68
SYK Stryker Corp	400.41	153.08B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	91.64	118.44B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	81.16	47.20B	5.69B	4.15B	623.10M	6.95

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jun-03-24	Resumed	Jefferies	Hold
Apr-03-24	Downgrade	Citigroup	Buy → Neutral
Dec-07-23	Initiated	UBS	Buy
Jun-16-23	Initiated	Wells Fargo	Overweight
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Jan-28-22	Reiterated	Citigroup	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-17-18	Initiated	Goldman	Buy
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-17	Initiated	Deutsche Bank	Hold
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy
Dec-18-09	Initiated	Maxim Group	Buy
Nov-06-09	Initiated	Jefferies & Co	Buy
Jul-17-09	Initiated	Soleil	Buy
Sep-26-07	Initiated	Banc of America Sec	Buy
Feb-23-07	Downgrade	Robert W. Baird	Outperform → Neutral

View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

Jul 30, 2025

Why is Bio Rad Laboratories Inc. stock attracting strong analyst attentionAI Powered Entry Points That Work - jammulinksnews.com

Jul 30, 2025

Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - Yahoo Finance

Jul 30, 2025

New Product Launches: Will They Boost Bio Rad Laboratories Inc. Stock in 2025 - metal.it

Jul 30, 2025

Jul 29, 2025

Bio-Rad Laboratories Appoints New Executive VP for Growth - The Globe and Mail

Jul 29, 2025

Epigenetics Market Set to Surpass USD 2.79 Billion by 2032 | Key - openPR.com

Jul 29, 2025

North America Autoimmune Disease Diagnostics Market Report - GlobeNewswire

Jul 29, 2025

North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers - GlobeNewswire Inc.

Jul 29, 2025

Human Papilloma Virus Testing Market Research Report - GlobeNewswire

Jul 29, 2025

Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche - Yahoo Finance

Jul 29, 2025

Nucleic Acid Isolation and Purification Market Outlook 2025 - openPR.com

Jul 29, 2025

Loop-Mediated Isothermal Amplification (LAMP) Market Outlook - openPR.com

Jul 29, 2025

Bio-Rad Laboratories A BIO 2025Q2 Earnings Preview Downside Ahead on Weak Demand for Clinical Diagnostics - AInvest

Jul 29, 2025

Jul 28, 2025

Bio-Rad Laboratories B BIO.B 2025Q2 Earnings Preview Downside Risk as Operating Income Declines - AInvest

Jul 28, 2025

Published on: 2025-07-29 03:10:13 - metal.it

Jul 28, 2025

Does Bio Rad Laboratories Inc. stock perform well during market downturnsValue Investing Recommendation For Every Investor - jammulinksnews.com

Jul 28, 2025

What are Bio Rad Laboratories Inc. company’s key revenue driversPost Market Outlook For Every Investor - jammulinksnews.com

Jul 28, 2025

Bio-Rad appoints Rajat Mehta as new EVP of global commercial operations - Investing.com Nigeria

Jul 28, 2025

Bio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial Operations - The Globe and Mail

Jul 28, 2025

How high can Bio Rad Laboratories Inc. stock price go in 2025Smart Allocation Stock Pick Insights Gaining Interest - beatles.ru

Jul 28, 2025

What are the technical indicators suggesting about Bio Rad Laboratories Inc.Stock Strategy Trend Scanner To Watch Now - jammulinksnews.com

Jul 28, 2025

Is Bio Rad Laboratories Inc. a growth stock or a value stockConsistent double returns - jammulinksnews.com

Jul 28, 2025

What makes Bio Rad Laboratories Inc. stock price move sharplyAchieve breakthrough investment performance - jammulinksnews.com

Jul 28, 2025

When is Bio Rad Laboratories Inc. stock expected to show significant growthBuild a portfolio that stands the test of time - jammulinksnews.com

Jul 28, 2025

NGS Sample Preparation Market Set to Witness Significant Growth - openPR.com

Jul 28, 2025

Is Bio Rad Laboratories Inc. stock overvalued or undervaluedGet timely alerts on market opportunities - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

How does Bio Rad Laboratories Inc. generate profit in a changing economyAchieve rapid returns with smart investment plans - jammulinksnews.com

Jul 27, 2025

How strong is Bio Rad Laboratories Inc. company’s balance sheetDiscover market opportunities with real-time data - jammulinksnews.com

Jul 27, 2025

Why Bio Rad Laboratories Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - metal.it

Jul 27, 2025

Jul 25, 2025